Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

6.4%

3 terminated/withdrawn out of 47 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

32%

15 trials in Phase 3/4

Results Transparency

56%

15 of 27 completed trials have results

Key Signals

5 recruiting15 with results

Enrollment Performance

Analytics

N/A

13(37.1%)

Phase 3

10(28.6%)

Phase 2

6(17.1%)

Phase 4

5(14.3%)

Phase 1

1(2.9%)

35Total

N/A(13)

Phase 3(10)

Phase 2(6)

Phase 4(5)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (47)

Showing 20 of 47 trials

NCT06610825Phase 2Recruiting

Castrate Resistant Prostate Cancer Enhertu Therapy

Role: lead

NCT04843761Phase 3Completed

ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

Role: collaborator

NCT06729593Phase 3Completed

Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Role: collaborator

NCT06729606Phase 3Completed

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Role: collaborator

NCT07155694Phase 4Not Yet Recruiting

Role of Finerenone in African American Veterans With Diabetic Kidney Disease

Role: lead

NCT03856879Not ApplicableCompleted

High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults

Role: collaborator

NCT06110130Phase 4Recruiting

Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD

Role: lead

NCT03730181Phase 1Completed

Tuberculosis Clinical Trials Consortium Study 35

Role: collaborator

NCT06906211Not ApplicableRecruiting

Low Intensity Focused Ultrasound for Chronic Pain: High Resolution Targeting of The Human Insula

Role: lead

NCT05780437Phase 3Completed

AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Role: collaborator

NCT06405074Not ApplicableRecruiting

Low Intensity Focused Ultrasound for Tobacco Use Disorder: High Resolution Targeting of the Human Insula

Role: lead

NCT06453109Not ApplicableRecruiting

Focused Ultrasound for the Complex Patient

Role: lead

NCT01350648Completed

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection

Role: collaborator

NCT03160313Not ApplicableTerminated

Effects of an Interdisciplinary Fitness and Social Engagement Intervention

Role: lead

NCT00815217Not ApplicableWithdrawn

The Role of Lipoaspirate Injection in the Treatment of Diabetic Lower Extremity Wounds and Venous Stasis Ulcers

Role: lead

NCT04969250Phase 4Completed

Vaccination for Recovered Inpatients With COVID-19 (VATICO)

Role: collaborator

NCT00867048Phase 4Completed

Strategic Timing of Antiretroviral Treatment

Role: collaborator

NCT01793519Phase 4Active Not Recruiting

Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis

Role: collaborator

NCT05780541Phase 3Terminated

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Role: collaborator

NCT05780463Phase 3Completed

MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Role: collaborator